IDNA (IDNA) Stock Price & Analysis
IDNA (IDNA) fell 0.79% to USD 39.46 as of September 8, 2026 at 16:46 UTC, according to Nexqual real-time market data.
IDNA last closed at USD 39.46; the session ranged USD 38.88–39.49 on volume of 94,925 shares. Market capitalization is —, with a 52-week range of USD 22.33–41.49 (PCX). Source: Nexqual, September 8, 2026 at 16:46 UTC.
Key Statistics (as of September 8, 2026 at 16:46 UTC)
| Price | USD 39.46 |
|---|---|
| Change | ▼ 0.79% (down) |
| Previous Close | USD 39.46 |
| Open | USD 39.46 |
| Day Range | USD 38.88 – 39.49 |
| 52-Week Range | USD 22.33 – 41.49 |
| Volume | 94,925 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (IDNA)
Nexqual's technical model rates IDNA "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 8, 2026 at 16:46 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 61.24 (neutral) |
| vs SMA50 | Above (USD 35.43) |
| MACD | 1.51 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GNOM | Global X Genomics & Biotechnolo | USD 63.74 | ▼ 1.89% |
| IHAK | iShares Cybersecurity and Tech | USD 62.04 | ▼ 2.39% |
| IDRV | iShares Self-Driving EV and Tec | USD 36.6 | ▼ 0.36% |
| XT | iShares Future Exponential Tech | USD 81.52 | ▼ 1.41% |
| PBE | Invesco Biotechnology & Genome | USD 95.28 | ▼ 3.48% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 16:46 UTC. This page is informational and not investment advice.